Weiguo Chen
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Health Informatics top 5%
Papers in
-
- Breast Cancer Treatment Studies 50
- Oncology 23
- HER2/EGFR in Cancer Research 9
- Co-authors
- Kunwei Shen (65 shared papers)Yafen Li (59 shared papers)Jiayi Wu (55 shared papers)Xiaosong Chen (53 shared papers)Ou Huang (52 shared papers)Li Zhu (46 shared papers)Jianrong He (47 shared papers)Genggeng Qin (37 shared papers)
- Journals
- Frontiers in Oncology (15 papers)BMC Cancer (5 papers)Oncotarget (5 papers)European Radiology (5 papers)Physics in Medicine and Biology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weiguo Chen
149 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 605
- Health Informatics 48
- Oncology 323
- Animal Science and Zoology 94
- Radiology, Nuclear Medicine and Imaging 201
Countries citing papers authored by Weiguo Chen
This map shows the geographic impact of Weiguo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Chen more than expected).
Fields of papers citing papers by Weiguo Chen
This network shows the impact of papers produced by Weiguo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Chen. The network helps show where Weiguo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiguo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 104 | |
| 2 | 2021 | 97 | |
| 3 | Fox-2 Splicing Factor Binds to a Conserved Intron Motif to Promote Inclusion of Protein \n4.1R Alternative Exon 16 | 2006 | 90 |
| 4 | 2017 | 80 | |
| 5 | 2018 | 69 | |
| 6 | MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer. | 2015 | 58 |
| 7 | 2004 | 55 | |
| 8 | 2013 | 55 | |
| 9 | 2023 | 54 | |
| 10 | 2017 | 52 | |
| 11 | 2021 | 51 | |
| 12 | 2019 | 48 | |
| 13 | 2003 | 47 | |
| 14 | 2016 | 46 | |
| 15 | 2020 | 46 | |
| 16 | 2022 | 45 | |
| 17 | 2001 | 44 | |
| 18 | 2015 | 37 | |
| 19 | 2016 | 36 | |
| 20 | 2021 | 36 |
About Weiguo Chen
Weiguo Chen is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Artificial Intelligence, having authored 165 papers that have together received 2.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (50 papers), AI in cancer detection (21 papers), Digital Radiography and Breast Imaging (13 papers), Radiomics and Machine Learning in Medical Imaging (10 papers), HER2/EGFR in Cancer Research (9 papers), Breast Lesions and Carcinomas (8 papers), Animal Virus Infections Studies (5 papers) and Bone Tumor Diagnosis and Treatments (5 papers). The work is most often cited by research in Cancer Research (605 citations), Health Informatics (48 citations), Oncology (323 citations), Animal Science and Zoology (94 citations) and Radiology, Nuclear Medicine and Imaging (201 citations). Weiguo Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kunwei Shen, Yafen Li, Jiayi Wu, Xiaosong Chen, Ou Huang, Li Zhu, Jianrong He, Genggeng Qin, Xiaochun Fei and Hui Zeng. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Oncotarget, European Radiology and Physics in Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.